ACETO Subsidiary, Rising Pharmaceuticals, Acquires Three FDA-Approved Ophthalmic ANDAs From Nexus Pharmaceuticals

By: via Benzinga
ACETO Corporation (NASDAQ: ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.